期刊
CANCER LETTERS
卷 283, 期 1, 页码 20-28出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2009.03.021
关键词
Gene therapy; Radiation tolerance; hTERT promoter; HRP/IAA; Laryngeal squamous cell carcinoma
类别
资金
- National Natural Science Foundation of China [30672438]
- Hubei Provincial Natural Science Foundation of China [2004ABA165, 2006ABC009]
Radioresistant cells have been shown to correlate with poor outcome after radiotherapy. Here, we found that human telomerase reverse transcriptase promoter (hTERTp) had lower activity in laryngeal squamous carcinomas cells than in radioresistant variant cells. Combining radiotherapy with plasmid phTERTp-HRP, in which expression of enzyme horseradish peroxidase (HRP) controlled by hTERTp, resulted in increased apoptosis and necrosis of tumor cells after prodrug indole-3-acetic acid (IAA; converted by HRP into a cytotoxin) incubation. Volume and wet weight of xenograft tumor were reduced more in the combination groups. These data suggest that hTERTp has potential use in targeted cancer gene therapy, especially for radioresistant tumors. Combining radiotherapy with hTERTp-HRP/IAA may overcome radioresistance in laryngeal squamous carcinomas cells and amplify the killing effect in targeted cancer cells. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据